Gal-3 blocks the binding between PD-1 and pembrolizumab (brand name: Keytruda)

1 week ago 10
submitted by /u/take-a-gamble
[link] [comments]
Read Entire Article
  1. Homepage
  2. Science
  3. Gal-3 blocks the binding between PD-1 and pembrolizumab (brand name: Keytruda)

Related

Climate justice beliefs related to climate action and policy support around the world - Nature Climate Change

Climate justice beliefs related to climate action and policy...

56 minutes ago 0
Type 2 Diabetes Linked to Accelerated Brain Shrinkage | According to a decades-long trial that began in 1995, those with type 2 diabetes lost significantly more white matter compared to those without a metabolic disease, and this group ultimately faced a 41% higher risk of mild cognitive impairment.

Type 2 Diabetes Linked to Accelerated Brain Shrinkage | Acco...

1 hour ago 0
Weight-Loss Drug Tirzepatide Reduces Heart Failure Deaths

Weight-Loss Drug Tirzepatide Reduces Heart Failure Deaths

1 hour ago 0

Hidden in mobile, Best for skyscrapers.